These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Recent developments of intravesical therapy of painful bladder syndrome/interstitial cystitis: a review. Toft BR; Nordling J Curr Opin Urol; 2006 Jul; 16(4):268-72. PubMed ID: 16770126 [TBL] [Abstract][Full Text] [Related]
7. Changes in sexual function of women with refractory interstitial cystitis/bladder pain syndrome after intravesical therapy with a hyaluronic acid solution. Hung MJ; Su TH; Lin YH; Huang WC; Lin TY; Hsu CS; Chuang FC; Tsai CP; Shen PS; Chen GD J Sex Med; 2014 Sep; 11(9):2256-63. PubMed ID: 24636240 [TBL] [Abstract][Full Text] [Related]
8. Intravesical treatment of bladder pain syndrome/interstitial cystitis: from the conventional regimens to the novel botulinum toxin injections. Dellis A; Papatsoris AG Expert Opin Investig Drugs; 2014 Jun; 23(6):751-7. PubMed ID: 24749738 [TBL] [Abstract][Full Text] [Related]
9. Hyaluronic acid improves pain symptoms more than bladder storage symptoms in women with interstitial cystitis. Hung MJ; Tsai CP; Lin YH; Huang WC; Chen GD; Shen PS Taiwan J Obstet Gynecol; 2019 May; 58(3):417-422. PubMed ID: 31122535 [TBL] [Abstract][Full Text] [Related]
10. Bridging pharmacotherapy and minimally invasive surgery in interstitial cystitis/bladder pain syndrome treatment. Dellis AE; Papatsoris AG Expert Opin Pharmacother; 2018 Aug; 19(12):1369-1373. PubMed ID: 30074829 [TBL] [Abstract][Full Text] [Related]
11. Update on Urinary Tract Markers in Interstitial Cystitis/Bladder Pain Syndrome. Grigorescu B; Powers K; Lazarou G Female Pelvic Med Reconstr Surg; 2016; 22(1):16-23. PubMed ID: 26571430 [TBL] [Abstract][Full Text] [Related]
12. Symptomatic overlap in overactive bladder and interstitial cystitis/bladder pain syndrome: development of a new algorithm. Ackerman AL; Lai HH; Parameshwar PS; Eilber KS; Anger JT BJU Int; 2019 Apr; 123(4):682-693. PubMed ID: 30253040 [TBL] [Abstract][Full Text] [Related]
14. Purinergic P2X7 receptors as therapeutic targets in interstitial cystitis/bladder pain syndrome; key role of ATP signaling in inflammation. Taidi Z; Mansfield KJ; Bates L; Sana-Ur-Rehman H; Liu L Bladder (San Franc); 2019; 6(1):e38. PubMed ID: 32775480 [TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical evidence suggests repeated intravesical application of botulinum toxin A injections may improve treatment efficacy of interstitial cystitis/bladder pain syndrome. Shie JH; Liu HT; Wang YS; Kuo HC BJU Int; 2013 Apr; 111(4):638-46. PubMed ID: 22943596 [TBL] [Abstract][Full Text] [Related]
16. Diffusion-Weighted Magnetic Resonance Imaging: A New Tool for the Diagnosis of Bladder Pain Syndrome/Interstitial Cystitis. Charlanes A; Boudghene F; Chesnel C; Ciofu C; Le Breton F; Jousse M; Amarenco G; Manceau P Urol Int; 2019; 102(1):109-112. PubMed ID: 30428470 [TBL] [Abstract][Full Text] [Related]
17. Elevated Urine Levels of Macrophage Migration Inhibitory Factor in Inflammatory Bladder Conditions: A Potential Biomarker for a Subgroup of Interstitial Cystitis/Bladder Pain Syndrome Patients. Vera PL; Preston DM; Moldwin RM; Erickson DR; Mowlazadeh B; Ma F; Kouzoukas DE; Meyer-Siegler KL; Fall M Urology; 2018 Jun; 116():55-62. PubMed ID: 29580781 [TBL] [Abstract][Full Text] [Related]
18. Stem Cell Therapy for Interstitial Cystitis/Bladder Pain Syndrome. Kim A; Shin DM; Choo MS Curr Urol Rep; 2016 Jan; 17(1):1. PubMed ID: 26686192 [TBL] [Abstract][Full Text] [Related]
19. Long-term outcomes of intravesical dimethyl sulfoxide/heparin/hydrocortisone therapy for interstitial cystitis/bladder pain syndrome. Lim YN; Dwyer P; Murray C; Karmakar D; Rosamilia A; Thomas E Int Urogynecol J; 2017 Jul; 28(7):1085-1089. PubMed ID: 27987022 [TBL] [Abstract][Full Text] [Related]
20. Interstitial cystitis/painful bladder syndrome. French LM; Bhambore N Am Fam Physician; 2011 May; 83(10):1175-81. PubMed ID: 21568251 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]